Zobrazeno 1 - 1
of 1
pro vyhledávání: '"cost reduction evaluation"'
Autor:
MV Avksentyeva, OV Shatalova
Publikováno v:
Медицинский совет, Vol 0, Iss 8, Pp 18-23 (2014)
Cost reduction associated with the use of rivaroxaban compared with the enoxaparin + warfarin combination for for deep vein thrombosis and pulmonary thromboembolism when treated in the inpatient setting. The choice of the cost reduction method is con
Externí odkaz:
https://doaj.org/article/a7cf9369d2a1498985e9a4ea259d4225
